Latest news with #ThobAlAseel
Yahoo
6 days ago
- Business
- Yahoo
Middle Eastern Penny Stocks To Watch: Union Insurance Company P.J.S.C Leads The Trio
The Middle Eastern stock markets have been experiencing a mix of highs and lows, with the Dubai index reaching multi-year peaks despite broader economic uncertainties. Amidst these fluctuations, investors are increasingly looking for opportunities in lesser-known segments like penny stocks. Though the term 'penny stock' might sound outdated, these smaller or newer companies can still offer surprising value when they possess strong financial underpinnings. Name Share Price Market Cap Financial Health Rating Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR) TRY1.67 TRY1.8B ★★★★★☆ Thob Al Aseel (SASE:4012) SAR3.99 SAR1.61B ★★★★★★ Alarum Technologies (TASE:ALAR) ₪2.70 ₪189.09M ★★★★★★ Terminal X Online (TASE:TRX) ₪4.339 ₪551.08M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.905 ₪2.81B ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.311 ₪171.8M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.734 AED446.46M ★★★★★★ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.00 AED361.51M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.03 AED2.08B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.41 AED10.29B ★★★★☆☆ Click here to see the full list of 95 stocks from our Middle Eastern Penny Stocks screener. Here's a peek at a few of the choices from the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Union Insurance Company P.J.S.C. provides insurance products across the United Arab Emirates, Gulf Cooperation Council, and internationally with a market capitalization of AED198.56 million. Operations: The company's revenue is derived from two main segments: Life Insurance, contributing AED16.83 million, and General Insurance, generating AED246.91 million. Market Cap: AED198.56M Union Insurance Company P.J.S.C. has recently become profitable, reporting a net income of AED 13.05 million for Q1 2025, up from AED 11.78 million the previous year. Despite a low return on equity at 15.4%, its debt-free status and favorable price-to-earnings ratio (5x) compared to the AE market (12.6x) suggest potential value for investors interested in penny stocks. However, challenges remain as short-term assets do not cover long-term liabilities of AED1.2 billion, and an inexperienced management team with an average tenure of just 1.4 years could impact strategic execution moving forward. Navigate through the intricacies of Union Insurance Company P.J.S.C with our comprehensive balance sheet health report here. Learn about Union Insurance Company P.J.S.C's historical performance here. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Thob Al Aseel Company engages in the development, import, export, wholesale, and retail of fabrics and readymade clothes, with a market cap of SAR1.61 billion. Operations: The company generates revenue primarily from Thobs, contributing SAR407.44 million, and Fabrics, with SAR124.63 million. Market Cap: SAR1.61B Thob Al Aseel reported robust earnings growth, with Q1 2025 net income rising to SAR 63.03 million from SAR 40.05 million the previous year, reflecting a strong profit margin improvement to 19.9%. Despite a relatively inexperienced board with an average tenure of 2.3 years, the company maintains a healthy balance sheet; short-term assets of SAR750.6 million comfortably cover both short and long-term liabilities totaling SAR205.7 million, while being debt-free eliminates interest payment concerns. Trading significantly below estimated fair value and demonstrating high-quality earnings growth faster than industry averages positions Thob Al Aseel as an intriguing option in the penny stock space. Take a closer look at Thob Al Aseel's potential here in our financial health report. Evaluate Thob Al Aseel's historical performance by accessing our past performance report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Inter Industries Plus Ltd., along with its subsidiaries, operates in the energy and infrastructure sectors in Israel, with a market cap of ₪100.72 million. Operations: Inter Industries Plus Ltd. does not report specific revenue segments. Market Cap: ₪100.72M Inter Industries Plus Ltd. operates in Israel's energy and infrastructure sectors, reporting a net loss of ₪0.802 million for Q1 2025 despite increased sales of ₪175.51 million from the previous year. The company remains unprofitable, with losses growing at an annual rate of 15.5% over five years, and a high net debt to equity ratio of 44.9%. However, it has reduced its debt from 107.3% to 63.7% over five years and maintains sufficient cash runway for more than a year based on current free cash flow, indicating financial resilience amidst challenges in profitability and earnings growth. Click here to discover the nuances of Inter Industries Plus with our detailed analytical financial health report. Review our historical performance report to gain insights into Inter Industries Plus' track record. Embark on your investment journey to our 95 Middle Eastern Penny Stocks selection here. Contemplating Other Strategies? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:UNION SASE:4012 and TASE:ININ. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-05-2025
- Business
- Yahoo
Middle Eastern Penny Stocks With Market Caps Under US$400M
As Gulf bourses display mixed results, with investors on the lookout for new catalysts amid fluctuating oil prices and shifting global trade dynamics, attention turns to the potential of smaller market players. Penny stocks, a term that may seem outdated, still hold relevance as they often represent smaller or newer companies with significant growth potential. This article will explore three such stocks from the Middle East that combine financial strength with promising opportunities for investors seeking hidden value. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.17 SAR1.67B ★★★★★★ Keir International (SASE:9542) SAR3.95 SAR474M ★★★★★☆ Alarum Technologies (TASE:ALAR) ₪2.797 ₪195.88M ★★★★★★ Terminal X Online (TASE:TRX) ₪4.535 ₪575.97M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.927 ₪2.88B ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.207 ₪164.07M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.701 AED426.39M ★★★★★★ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED2.88 AED332.64M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.00 AED2.02B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.38 AED10.03B ★★★★☆☆ Click here to see the full list of 93 stocks from our Middle Eastern Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Gulf Pharmaceutical Industries P.S.C., along with its subsidiaries, operates in the manufacturing and sale of medicines, drugs, and various pharmaceutical, cosmetic, and medical compounds across the United Arab Emirates, other GCC countries, and internationally with a market cap of AED1.59 billion. Operations: The company's revenue is primarily derived from its Manufacturing segment, which generated AED864.9 million, and its Planet segment, contributing AED732.9 million. Market Cap: AED1.59B Gulf Pharmaceutical Industries P.S.C. has demonstrated significant financial improvement, becoming profitable over the past year with a net income of AED 140.9 million in Q1 2025, up from AED 1.9 million the previous year. The company maintains strong short-term asset coverage over both its short and long-term liabilities, and its debt is well managed with a satisfactory net debt to equity ratio of 4.8%. Despite low return on equity at 2.4%, earnings quality remains high, supported by stable weekly volatility and reduced debt levels from previous years, reflecting prudent financial management amidst growing revenues forecasted at 6.91% annually. Get an in-depth perspective on Gulf Pharmaceutical Industries P.S.C's performance by reading our balance sheet health report here. Understand Gulf Pharmaceutical Industries P.S.C's earnings outlook by examining our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Sinpas Gayrimenkul Yatirim Ortakligi, originally established as Sinpas Insaat in 2006 and transformed into a Real Estate Investment Partnership in 2007, operates in the real estate sector with a market capitalization of TRY15.08 billion. Operations: The company generates revenue of TRY13.44 billion from its residential real estate developments segment. Market Cap: TRY15.08B Sinpas Gayrimenkul Yatirim Ortakligi has shown impressive earnings growth, with a 210.1% increase over the past year, outpacing its five-year average of 33.4%. The company's debt management is robust, evidenced by a net debt to equity ratio of 11.1%, and its operating cash flow comfortably covers debt obligations at 33.3%. However, interest coverage remains a concern at only 2.3 times EBIT. Despite large one-off gains impacting recent financial results and declining profit margins from last year, the company trades at an attractive price-to-earnings ratio of 2.9x compared to the broader market's 19.1x. Dive into the specifics of Sinpas Gayrimenkul Yatirim Ortakligi here with our thorough balance sheet health report. Examine Sinpas Gayrimenkul Yatirim Ortakligi's past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Alarum Technologies Ltd. offers web data collection solutions across multiple regions including the Americas, Europe, Southeast Asia, the Middle East, and Africa, with a market cap of ₪195.88 million. Operations: Alarum Technologies generates revenue from web data collection ($30.91 million), advertising services ($0.04 million), and consumer internet access ($0.87 million). Market Cap: ₪195.88M Alarum Technologies, with a market cap of ₪195.88 million, has demonstrated profitability with earnings of US$5.78 million for 2024, rebounding from a previous net loss. Its revenue streams are diversified across web data collection and consumer internet access. The company's debt management is strong, with cash exceeding total debt and operating cash flow covering debt by over 900%. However, the stock remains highly volatile and faces legal challenges due to a class action lawsuit in the U.S., which could impact investor sentiment despite its solid financial footing and high return on equity at 21.9%. Unlock comprehensive insights into our analysis of Alarum Technologies stock in this financial health report. Assess Alarum Technologies' future earnings estimates with our detailed growth reports. Access the full spectrum of 93 Middle Eastern Penny Stocks by clicking on this link. Ready For A Different Approach? Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:JULPHAR IBSE:SNGYO and TASE:ALAR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16-05-2025
- Business
- Yahoo
Middle Eastern Market: Apex Investment PSC And 2 Other Promising Penny Stocks
As most Gulf markets settle higher, investors are closely watching the potential impacts of a U.S.-China trade truce on the Middle Eastern economy. Amidst these developments, penny stocks—typically representing smaller or newer companies—remain an intriguing investment area despite being considered somewhat outdated. In this article, we explore three such stocks that demonstrate strong financial health and present promising opportunities for investors seeking hidden value in quality companies. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.19 SAR1.68B ★★★★★★ Keir International (SASE:9542) SAR3.92 SAR474M ★★★★★☆ Alarum Technologies (TASE:ALAR) ₪2.788 ₪195.25M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.912 ₪2.84B ★★★★★☆ Tarya Israel (TASE:TRA) ₪0.57 ₪169.21M ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.222 ₪165.19M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.705 AED428.82M ★★★★★★ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.36 AED388.08M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.00 AED2.02B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.36 AED10.03B ★★★★☆☆ Click here to see the full list of 94 stocks from our Middle Eastern Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Apex Investment PSC is engaged in the manufacturing, distribution, and sale of clinkers and cement products both within the United Arab Emirates and internationally, with a market cap of AED14.78 billion. Operations: The company's revenue is primarily derived from catering (AED600.69 million), manufacturing (AED222.78 million), facility management services (AED107.89 million), and contracting (AED40.20 million). Market Cap: AED14.78B Apex Investment PSC, despite its significant market cap of AED14.78 billion, faces challenges typical for penny stocks. The company reported a net loss of AED25.6 million in Q1 2025, contrasting with a profit the previous year. Despite being debt-free and having short-term assets significantly exceeding liabilities, Apex's earnings have been negatively impacted by large one-off losses and volatile share prices. Its return on equity is low at 2.3%, and profit margins have decreased to 5.4% from last year's 17.6%. While it has experienced board members, earnings growth has been negative recently, complicating comparisons with industry averages. Jump into the full analysis health report here for a deeper understanding of Apex Investment PSC. Review our historical performance report to gain insights into Apex Investment PSC's track record. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Ihlas Holding A.S. operates in construction and real estate, media, manufacturing and trading, as well as healthcare and education sectors in Turkey and internationally, with a market cap of TRY3.49 billion. Operations: The company's revenue is primarily derived from its marketing segment at TRY4.22 billion, followed by media at TRY2.29 billion and construction at TRY1.88 billion. Market Cap: TRY3.49B Ihlas Holding A.S., with a market cap of TRY3.49 billion, operates across various sectors but remains unprofitable, highlighted by a negative return on equity of -18.34%. Despite this, the company has reduced its debt to equity ratio significantly over five years and maintains more cash than total debt. Recent earnings showed sales at TRY10.34 billion with a net loss of TRY1.38 billion, reversing from last year's profit. While short-term assets cover liabilities comfortably and shareholders haven't faced dilution recently, the stock's high volatility poses challenges typical for penny stocks in the region. Take a closer look at Ihlas Holding's potential here in our financial health report. Evaluate Ihlas Holding's historical performance by accessing our past performance report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Imed Infinity Medical-Limited Partnership is a research and development partnership that invests in medical field projects, mainly in digital health, with a market cap of ₪6.73 million. Operations: The partnership's revenue is primarily derived from its venture capital activities, amounting to $0.041 million. Market Cap: ₪6.73M Imed Infinity Medical-Limited Partnership, with a market cap of ₪6.73 million, is pre-revenue, generating US$0.041 million primarily from venture capital activities in digital health projects. The partnership reported a net loss of US$0.575 million for 2024, showing improvement from the previous year's larger loss. Despite its unprofitability and negative return on equity (-7.63%), Imed Infinity has no debt and sufficient cash runway exceeding one year based on current free cash flow levels. The management team is relatively new with an average tenure of 1.3 years, while the experienced board provides stability amidst high share price volatility common in penny stocks. Get an in-depth perspective on Imed Infinity Medical-Limited Partnership's performance by reading our balance sheet health report here. Learn about Imed Infinity Medical-Limited Partnership's historical performance here. Reveal the 94 hidden gems among our Middle Eastern Penny Stocks screener with a single click here. Seeking Other Investments? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:APEX IBSE:IHLAS and TASE:IMED. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12-05-2025
- Business
- Yahoo
Middle Eastern Penny Stocks With Market Caps Over US$60M To Watch
As the Middle Eastern markets navigate the complexities of global trade tensions, particularly between the U.S. and China, investors are keeping a close eye on regional indices that have shown mixed performances. In this context, penny stocks—though an older term—continue to represent smaller or less-established companies that might offer significant value to discerning investors. By focusing on those with solid financials and growth potential, these stocks can provide unique opportunities for those looking beyond traditional investment options. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.13 SAR1.58B ★★★★★★ Keir International (SASE:9542) SAR3.92 SAR474M ★★★★★☆ Dna Group (T.R.) (TASE:DNA) ₪0.999 ₪123.04M ★★★★★★ Alarum Technologies (TASE:ALAR) ₪2.446 ₪171.3M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.922 ₪2.87B ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.222 ₪165.19M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.709 AED425.78M ★★★★★★ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.40 AED390.39M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.03 AED2.1B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.36 AED10.03B ★★★★☆☆ Click here to see the full list of 95 stocks from our Middle Eastern Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Ihlas Yayin Holding A.S. operates in Turkey through its subsidiaries, focusing on media, publishing, and advertising businesses with a market cap of TRY940.50 million. Operations: The company generates revenue from several segments, including Journalism and Printing Works (TRY1.77 billion), News Agencies (TRY389.08 million), and TV Services and Other (TRY318.35 million). Market Cap: TRY940.5M Ihlas Yayin Holding's financial landscape presents a mixed picture for investors considering penny stocks. The company's revenue of TRY2.48 billion reflects a slight decline from the previous year, while it remains unprofitable with a net loss of TRY227.23 million. Despite this, the company has more cash than debt and its short-term assets exceed short-term liabilities, indicating some financial resilience. However, its cash runway is less than one year if free cash flow continues to shrink at historical rates. The board's average tenure of 5.3 years suggests experienced governance amidst these challenges. Jump into the full analysis health report here for a deeper understanding of Ihlas Yayin Holding. Gain insights into Ihlas Yayin Holding's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Metro Ticari ve Mali Yatirimlar Holding A.S. operates as a diversified holding company with various business interests, and it has a market capitalization of TRY1.33 billion. Operations: The company generates revenue primarily from its Transportation - Railroads segment, amounting to TRY28.73 million. Market Cap: TRY1.33B Metro Ticari ve Mali Yatirimlar Holding, with a market cap of TRY1.33 billion, operates without debt and has not diluted shareholders recently. Despite generating TRY28.73 million in revenue primarily from its railroads segment, the company remains unprofitable with a significant net loss of TRY1,085.84 million for the past year. Its short-term assets exceed liabilities but fall short against long-term obligations of TRY219.6 million. The firm boasts a cash runway exceeding three years if current free cash flow remains stable, supported by an experienced board averaging 4.8 years in tenure amidst financial challenges and volatility stability over the past year. Unlock comprehensive insights into our analysis of Metro Ticari ve Mali Yatirimlar Holding stock in this financial health report. Assess Metro Ticari ve Mali Yatirimlar Holding's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Bonus BioGroup Ltd. is a clinical-stage biotechnology company focused on developing tissue engineering and cell therapy products, with a market cap of ₪230.08 million. Operations: Bonus BioGroup Ltd. currently has no reported revenue segments. Market Cap: ₪230.08M Bonus BioGroup Ltd., with a market cap of ₪230.08 million, is a pre-revenue clinical-stage biotechnology company focusing on tissue engineering and cell therapy products. The firm recently secured FDA clearance for a Phase III clinical study of MesenCure™, targeting respiratory distress in severely ill patients. Despite its potential, the company faces financial challenges, including short-term assets that do not cover liabilities and a cash runway limited to three months before recent capital raising efforts. While debt-free and led by an experienced management team, Bonus BioGroup's stock remains highly volatile with no significant revenue streams yet established. Click here and access our complete financial health analysis report to understand the dynamics of Bonus BioGroup. Gain insights into Bonus BioGroup's past trends and performance with our report on the company's historical track record. Gain an insight into the universe of 95 Middle Eastern Penny Stocks by clicking here. Curious About Other Options? This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:IHYAY IBSE:METRO and TASE:BONS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12-05-2025
- Business
- Yahoo
Middle Eastern Penny Stocks With Market Caps Over US$60M To Watch
As the Middle Eastern markets navigate the complexities of global trade tensions, particularly between the U.S. and China, investors are keeping a close eye on regional indices that have shown mixed performances. In this context, penny stocks—though an older term—continue to represent smaller or less-established companies that might offer significant value to discerning investors. By focusing on those with solid financials and growth potential, these stocks can provide unique opportunities for those looking beyond traditional investment options. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.13 SAR1.58B ★★★★★★ Keir International (SASE:9542) SAR3.92 SAR474M ★★★★★☆ Dna Group (T.R.) (TASE:DNA) ₪0.999 ₪123.04M ★★★★★★ Alarum Technologies (TASE:ALAR) ₪2.446 ₪171.3M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.922 ₪2.87B ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.222 ₪165.19M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.709 AED425.78M ★★★★★★ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.40 AED390.39M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.03 AED2.1B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.36 AED10.03B ★★★★☆☆ Click here to see the full list of 95 stocks from our Middle Eastern Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Ihlas Yayin Holding A.S. operates in Turkey through its subsidiaries, focusing on media, publishing, and advertising businesses with a market cap of TRY940.50 million. Operations: The company generates revenue from several segments, including Journalism and Printing Works (TRY1.77 billion), News Agencies (TRY389.08 million), and TV Services and Other (TRY318.35 million). Market Cap: TRY940.5M Ihlas Yayin Holding's financial landscape presents a mixed picture for investors considering penny stocks. The company's revenue of TRY2.48 billion reflects a slight decline from the previous year, while it remains unprofitable with a net loss of TRY227.23 million. Despite this, the company has more cash than debt and its short-term assets exceed short-term liabilities, indicating some financial resilience. However, its cash runway is less than one year if free cash flow continues to shrink at historical rates. The board's average tenure of 5.3 years suggests experienced governance amidst these challenges. Jump into the full analysis health report here for a deeper understanding of Ihlas Yayin Holding. Gain insights into Ihlas Yayin Holding's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Metro Ticari ve Mali Yatirimlar Holding A.S. operates as a diversified holding company with various business interests, and it has a market capitalization of TRY1.33 billion. Operations: The company generates revenue primarily from its Transportation - Railroads segment, amounting to TRY28.73 million. Market Cap: TRY1.33B Metro Ticari ve Mali Yatirimlar Holding, with a market cap of TRY1.33 billion, operates without debt and has not diluted shareholders recently. Despite generating TRY28.73 million in revenue primarily from its railroads segment, the company remains unprofitable with a significant net loss of TRY1,085.84 million for the past year. Its short-term assets exceed liabilities but fall short against long-term obligations of TRY219.6 million. The firm boasts a cash runway exceeding three years if current free cash flow remains stable, supported by an experienced board averaging 4.8 years in tenure amidst financial challenges and volatility stability over the past year. Unlock comprehensive insights into our analysis of Metro Ticari ve Mali Yatirimlar Holding stock in this financial health report. Assess Metro Ticari ve Mali Yatirimlar Holding's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Bonus BioGroup Ltd. is a clinical-stage biotechnology company focused on developing tissue engineering and cell therapy products, with a market cap of ₪230.08 million. Operations: Bonus BioGroup Ltd. currently has no reported revenue segments. Market Cap: ₪230.08M Bonus BioGroup Ltd., with a market cap of ₪230.08 million, is a pre-revenue clinical-stage biotechnology company focusing on tissue engineering and cell therapy products. The firm recently secured FDA clearance for a Phase III clinical study of MesenCure™, targeting respiratory distress in severely ill patients. Despite its potential, the company faces financial challenges, including short-term assets that do not cover liabilities and a cash runway limited to three months before recent capital raising efforts. While debt-free and led by an experienced management team, Bonus BioGroup's stock remains highly volatile with no significant revenue streams yet established. Click here and access our complete financial health analysis report to understand the dynamics of Bonus BioGroup. Gain insights into Bonus BioGroup's past trends and performance with our report on the company's historical track record. Gain an insight into the universe of 95 Middle Eastern Penny Stocks by clicking here. Curious About Other Options? This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:IHYAY IBSE:METRO and TASE:BONS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
